Skip to main content

PKP's family first. Valeant apology.

Concordia in the news
Posted on May 3, 2016

Concordia in the news features stories of Concordians who appear in the news. Discover alumni, students, faculty and experts who recently made an impact in the media.

Expert commentators

Concordia faculty and researchers are regularly asked to offer expert, informed opinions on many of today's most pressing problems. Read some of the latest news items about Concordians:

  • Guy Lachapelle, professor in the Department of Political Science,  is quoted in a Canadian Press article about the resignation of Pierre Karl Péladeau as leader of the Parti Québécois. Lachapelle talks about Péladeau's legacy as party leader and his efforts to rally economic players to the sovereignist cause. The article notes that Lachapelle is a member of the board of directors of the recently-formed Institut de recherche sur l’autodétermination des peuples et les indépendances nationales (IRAI), established by Péladeau to direct research into economic and other aspects of sovereignty. The Canadian Press article is picked up by numerous media: Maclean's, Toronto Sun,Metro News Canada, The Chronicle Journal, Sudbury.com, Blackburn News, The Charlottetown Guardian, The Kelowna Daily Courier, Life in Quebec and more than forty others. Lachapelle is quoted also in other news articles: he tells Vice that the appearance by Péladeau's estranged wife Julie Snyder on the set of Radio Canada's 'Tout le Monde en Parle', Sunday evening, may have weighed heavily in Péladeau's decision; Lachapelle is paraphrased in an article in The Toronto Star, reprised in the Star's e-edition, Our Windsor and Hamilton News, which notes that the Concordia professor is a former candidate for the Parti Québécois; Lachapelle appeared earlier this morning on the set of Breakfast Television Montreal (no link available).
  • Lea Prevel Katsanis, professor in the Department of Marketing, is paraphrased in a piece in The Indian Panorama about Valeant Pharmaceuticals CEO Michael Pearson's testimony at last week's U.S. Senate special committee on drug price increases.